atopic

tylim Health Canada has authorized Eli Lilly’s atopic dermatitis treatment Ebglyss (lebrikizumab). The biologic is a first-line therapy for those 12 years and older. Ebglyss is given every four weeks, and trials showed that skin clearance and itch relief was seen as soon as four weeks. Ebglyss was approved inContinue Reading